News & Breakthroughs at Siteman
Stay informed with the latest cancer news and breakthroughs from Siteman Cancer Center. Our news feed provides timely updates on research breakthroughs, clinical trials, and community events.
Clinical, In the Media
Siteman Cancer Center opens expanded St. Charles County facility
Siteman Cancer Center will open its newly expanded and renovated outpatient facility at Barnes-Jewish St. Peters Hospital in St. Charles County on May 1. The expansion nearly doubles the facility’s size, to 37,000 square feet. With the larger capacity, additional physicians will be available to see patients in newly added exam and treatment rooms. The […]
Prevention
Experts call for increased efforts to prevent cancer
That the first public health revolution occurred more than a century ago might surprise people, according to some historians. Before the discovery of penicillin or the polio vaccine, life expectancy improved dramatically because of relatively simple ideas implemented on a massive scale, including improved sanitation, safer food storage and quarantines to prevent the spread of […]
Research
Online database aims to collect, organize research on cancer mutations
The body of knowledge on cancer genomics is massive and ever-expanding. But this wealth of potentially critical information is far less likely to be of help to patients if it is inaccessible to the doctors who treat them. Researchers at Washington University School of Medicine in St. Louis have developed an online “knowledgebase” intended for […]
Research
New insight into origin of stomach cancer
Conventional wisdom holds that the loss of cells that secrete acid in the stomach leads to a condition that eventually can develop into stomach cancer. But new research at Washington University School of Medicine and Siteman Cancer Center at Barnes-Jewish Hospital and Washington University in St. Louis indicates otherwise. Researchers found that damage to acid-secreting […]
Research
Study unveils new way to starve tumors to death
For decades, scientists have tried to halt cancer by blocking nutrients from reaching tumor cells, in essence starving tumor cells of the fuel needed to grow and proliferate. Such attempts often have disappointed because cancer cells are nimble, relying on numerous backup routes to continue growing. Now, scientists at Washington University School of Medicine in […]
Clinical
Prostate cancer detection made easier—and safer
Let’s say you’re a person with a prostate, and you’ve just had that gland checked with a prostate-specific antigen (PSA) test. Results show an elevated PSA level, which may or may not mean you have cancer. What do you do next? If you are being cared for by a Washington University urologic surgeon at Barnes-Jewish […]
Clinical
A complete toolkit for brain-tumor treatment
Every week, the brain tumor and neuro-oncology program at the Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine holds a tumor board meeting. Attending are specialists in the field of brain-tumor diagnosis and treatment: neurosurgeons, neuro-oncologists, neuro-radiation oncologists, endocrinologists and neuro-intensivists, as well as representatives from psychology, neurology, genetics, […]
Research
Immunotherapy for newly diagnosed endometrial cancer
For the first time ever, investigators are studying immunotherapy for patients with newly diagnosed endometrial cancer. The trial uses pembrolizumab, a programmed death receptor-1 (PD-1) inhibitor. The drug is currently approved by the Food and Drug Administration for treatment of advanced melanoma and metastatic non-small-cell lung cancer. “Pembrolizumab has been studied in patients with relapsed […]
In the Media
Siteman Investment Program awards $2.2 million in cancer research grants
Research on breast cancer and the effects of chemotherapy are among the seven projects that will benefit from $2.2 million in new grants announced by Siteman Cancer Center through its Siteman Investment Program. The goal of the grants is to support and accelerate the pace of innovation in cancer research. The money awarded comes from a variety of sources: […]
Research
Pathway linked to slower aging also fuels brain cancer
While a particular metabolic pathway shows potential to slow down the aging process, new research indicates a downside: That same pathway may drive brain cancer. The pathway, known as the nicotinamide adenine dinucleotide (NAD+) pathway, is overactive in a deadly form of brain cancer known as glioblastoma, according to a study by researchers at Washington […]